blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2184295

EP2184295 - POLYPEPTIDES HAVING ANTICANCER ACTIVITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.02.2016
Database last updated on 29.10.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BG, CY, HU, SE, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
Sinobioway Biomedicine Co., Ltd.
Xiamen PKU BIOPARK
80 Jinshang Rd.
Xiamen, Fujian 361009 / CN
[2015/16]
Former [2010/19]For all designated states
Xiamen Bioway Biotech Co., Limited
Beida Biological Garden No.80 Jinshang Road Huli District
Xiamen Fujian 361009 / CN
Inventor(s)01 / LIANG, Songping
Xiamen Bioway Biotech Co. Limited
Beida Biological Garden
No.80 Jinshang Road
Huli District
Xiamen Fujian 361009 / CN
02 / LIU, Zhonghua
Xiamen Bioway Biotech Co. Limited
Beida Biological Garden
No.80 Jinshang Road
Huli District
Xiamen Fujian 361009 / CN
 [2015/17]
Former [2010/19]01 / LIANG, Songping
Xiamen Bioway Biotech Co. Limited Beida Biological Garden No.80 Jinshang Road Huli District
Xiamen Fujian 361009 / CN
02 / LIU, Zhonghua
Xiamen Bioway Biotech Co. Limited Beida Biological Garden No.80 Jinshang Road Huli District
Xiamen Fujian 361009 / CN
Representative(s)Hryszkiewicz, Danuta
Kancelaria Patentowa
Matthias Scholl, Inc.
Skrytka Pocztowa 13
75-454 Koszalin / PL
[2015/17]
Former [2010/19]Hryszkiewicz, Danuta
Kancelaria Patentowa Matthias Scholl, Inc. Ul. Jana z Kolna 38
75-204 Koszalin / PL
Application number, filing date08783797.730.07.2008
[2010/19]
WO2008CN71804
Priority number, dateCN200713547831.07.2007         Original published format: CN200710035478
[2010/19]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009015602
Date:05.02.2009
Language:ZH
[2009/06]
Type: A1 Application with search report 
No.:EP2184295
Date:12.05.2010
Language:EN
[2010/19]
Type: B1 Patent specification 
No.:EP2184295
Date:22.04.2015
Language:EN
[2015/17]
Search report(s)International search report - published on:CN05.02.2009
(Supplementary) European search report - dispatched on:EP16.09.2010
ClassificationIPC:A61K38/00, C07K14/435, A61P35/00
[2014/47]
CPC:
C07K14/43518 (EP,US); A61P35/00 (EP); A61K38/00 (EP,US)
Former IPC [2010/19]C07K14/435, A61P35/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/17]
Former [2010/19]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:POLYPEPTIDE MIT ANTIKREBSWIRKUNG[2010/19]
English:POLYPEPTIDES HAVING ANTICANCER ACTIVITY[2010/19]
French:POLYPEPTIDES POSSÉDANT UNE ACTIVITÉ ANTICANCÉREUSE[2010/19]
Entry into regional phase26.02.2010Translation filed 
26.02.2010National basic fee paid 
26.02.2010Search fee paid 
26.02.2010Designation fee(s) paid 
26.02.2010Examination fee paid 
Examination procedure26.02.2010Examination requested  [2010/19]
27.10.2010Despatch of a communication from the examining division (Time limit: M06)
06.05.2011Reply to a communication from the examining division
31.01.2013Despatch of a communication from the examining division (Time limit: M04)
30.05.2013Reply to a communication from the examining division
05.11.2014Communication of intention to grant the patent
04.03.2015Fee for grant paid
04.03.2015Fee for publishing/printing paid
05.03.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.10.2010
Opposition(s)25.01.2016No opposition filed within time limit [2016/13]
Fees paidRenewal fee
23.07.2010Renewal fee patent year 03
19.07.2011Renewal fee patent year 04
09.07.2012Renewal fee patent year 05
05.07.2013Renewal fee patent year 06
18.07.2014Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.07.2008
AT22.04.2015
BE22.04.2015
BG22.04.2015
CY22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
IT22.04.2015
LT22.04.2015
LV22.04.2015
MC22.04.2015
MT22.04.2015
NL22.04.2015
PL22.04.2015
RO22.04.2015
SE22.04.2015
SI22.04.2015
SK22.04.2015
TR22.04.2015
NO22.07.2015
GR23.07.2015
IE30.07.2015
LU30.07.2015
CH31.07.2015
LI31.07.2015
IS22.08.2015
PT24.08.2015
[2017/39]
Former [2017/21]AT22.04.2015
BE22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
IT22.04.2015
LT22.04.2015
LV22.04.2015
MC22.04.2015
MT22.04.2015
NL22.04.2015
PL22.04.2015
RO22.04.2015
SI22.04.2015
SK22.04.2015
NO22.07.2015
GR23.07.2015
IE30.07.2015
LU30.07.2015
CH31.07.2015
LI31.07.2015
IS22.08.2015
PT24.08.2015
Former [2016/37]AT22.04.2015
BE22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
IT22.04.2015
LT22.04.2015
LV22.04.2015
MC22.04.2015
NL22.04.2015
PL22.04.2015
RO22.04.2015
SI22.04.2015
SK22.04.2015
NO22.07.2015
GR23.07.2015
IE30.07.2015
LU30.07.2015
CH31.07.2015
LI31.07.2015
IS22.08.2015
PT24.08.2015
Former [2016/33]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
IT22.04.2015
LT22.04.2015
LV22.04.2015
MC22.04.2015
NL22.04.2015
PL22.04.2015
RO22.04.2015
SI22.04.2015
SK22.04.2015
NO22.07.2015
GR23.07.2015
IE30.07.2015
LU30.07.2015
CH31.07.2015
LI31.07.2015
IS22.08.2015
PT24.08.2015
Former [2016/24]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
IT22.04.2015
LT22.04.2015
LV22.04.2015
MC22.04.2015
NL22.04.2015
PL22.04.2015
RO22.04.2015
SI22.04.2015
SK22.04.2015
NO22.07.2015
GR23.07.2015
LU30.07.2015
CH31.07.2015
LI31.07.2015
IS22.08.2015
PT24.08.2015
Former [2016/22]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
IT22.04.2015
LT22.04.2015
LV22.04.2015
MC22.04.2015
NL22.04.2015
PL22.04.2015
RO22.04.2015
SK22.04.2015
NO22.07.2015
GR23.07.2015
LU30.07.2015
CH31.07.2015
LI31.07.2015
IS22.08.2015
PT24.08.2015
Former [2016/21]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
IT22.04.2015
LT22.04.2015
LV22.04.2015
MC22.04.2015
NL22.04.2015
PL22.04.2015
RO22.04.2015
SK22.04.2015
NO22.07.2015
GR23.07.2015
LU30.07.2015
IS22.08.2015
PT24.08.2015
Former [2016/15]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
LT22.04.2015
LV22.04.2015
MC22.04.2015
NL22.04.2015
PL22.04.2015
RO22.04.2015
SK22.04.2015
NO22.07.2015
GR23.07.2015
LU30.07.2015
IS22.08.2015
PT24.08.2015
Former [2016/13]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
LT22.04.2015
LV22.04.2015
MC22.04.2015
NL22.04.2015
PL22.04.2015
RO22.04.2015
SK22.04.2015
NO22.07.2015
GR23.07.2015
IS22.08.2015
PT24.08.2015
Former [2016/10]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
LT22.04.2015
LV22.04.2015
NL22.04.2015
PL22.04.2015
RO22.04.2015
SK22.04.2015
NO22.07.2015
GR23.07.2015
IS22.08.2015
PT24.08.2015
Former [2016/09]AT22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
LT22.04.2015
LV22.04.2015
NL22.04.2015
NO22.07.2015
GR23.07.2015
IS22.08.2015
PT24.08.2015
Former [2016/07]AT22.04.2015
DK22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
LT22.04.2015
LV22.04.2015
NL22.04.2015
NO22.07.2015
GR23.07.2015
IS22.08.2015
PT24.08.2015
Former [2015/51]AT22.04.2015
ES22.04.2015
FI22.04.2015
HR22.04.2015
LT22.04.2015
LV22.04.2015
NL22.04.2015
NO22.07.2015
GR23.07.2015
IS22.08.2015
PT24.08.2015
Former [2015/50]ES22.04.2015
FI22.04.2015
HR22.04.2015
LT22.04.2015
LV22.04.2015
NL22.04.2015
NO22.07.2015
GR23.07.2015
IS22.08.2015
PT24.08.2015
Former [2015/49]ES22.04.2015
FI22.04.2015
HR22.04.2015
LT22.04.2015
LV22.04.2015
NL22.04.2015
NO22.07.2015
GR23.07.2015
PT24.08.2015
Former [2015/42]NL22.04.2015
Documents cited:Search[A]WO03101475  (TRANSMOLECULAR INC [US], et al) [A] 1-5 * the whole document *;
 [A]  - LEWIS RICHARD J ET AL, "Therapeutic potential of venom peptides", NATURE REVIEWS. DRUG DISCOVERY, NATURE PUBLISHING GROUP, GB LNKD- DOI:10.1038/NRD1197, (20031001), vol. 2, no. 10, ISSN 1474-1784, pages 790 - 802, XP002437775 [A] 1-5 * the whole document *

DOI:   http://dx.doi.org/10.1038/nrd1197
International search[A]US5756462  (KELBAUGH PAUL R [US], et al) [A] 1-5 * see abstract, claim 1 *;
 [PX]CN101168563  (XIAMEN BEIDAZHILU BIOLOG ENGIN [CN]) [PX] 1 * , see claim 1 *;
 [A]  - BUDNIK, B.A. et al., "De novo sequencing of antimicrobial peptides isolated the venom glands of the wolf spider Lycosa singoriensis", Journal of Mass Spectrometry, (20040000), vol. 39, no. 2, pages 193 - 201, XP008131824 [A] 1-5 * , see abstract and table 1 *

DOI:   http://dx.doi.org/10.1002/jms.577
 [A]  - YAN, L.Z. et al., "Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis", The Journal of Biological Chemistry, (19980000), vol. 273, no. 4, pages 2059 - 2066, XP008131812 [A] 1-5 * , see abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.